CHEST Prevention Of VTE In Nonsurgical Patients Guideline Summary - Guideline Central
Recommendations
Document Overview

Prevention Of VTE In Nonsurgical Patients

American College of Chest Physicians


Publication Date: Feb 1, 2012

Page Last Updated: May 5, 2026

Grading Recommendations

 Grade Description
1 Recommendation: indicates confidence that the benefits of the intervention clearly outweigh harms.
2 Suggestion: indicates greater uncertainty: although the benefits of the statement are still viewed as outweighing the harms, balance of benefits and harms is more difficult to judge, or the benefits or the harms may be less clear. With a suggestion, patient values and preferences may be more variable, and this can influence the clinical decision that is ultimately made.
 Grade Strength of Evidence
A High: high confidence that the evidence reflects the true effect. Further research is very unlikely to change our confidence in the estimate of effect.
B Moderate: moderate confidence that the evidence reflects the true effect. Further research may change our confidence in the estimate of effect and may change the estimate.
C Low: low confidence that the evidence reflects the true effect. Further research is likely to change our confidence in the estimate of effect and is likely to change the estimate.

Document Overview

Document Title
Prevention Of VTE In Nonsurgical Patients
Authoring Society

American College of Chest Physicians

Document Publication Date
Feb 1, 2012
Page Last Reviewed/Updated
May 5, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
journal.chestnet.org/article/S0012-3692(12)60124-X/fulltext
Source Citation

DOI: https://doi.org/10.1378/chest.11-2296

Document Scope, Criteria, and Use Cases

Document Objectives

This guideline addressed VTE prevention in hospitalized medical patients, outpatients with cancer, the chronically immobilized, long-distance travelers, and those with asymptomatic thrombophilia.

Scope
Assessment and Screening, Management, Prevention
Diseases/Conditions (MeSH)

D054556 - Venous Thromboembolism

D000925 - Anticoagulants

D011315 - Preventive Medicine

D057236 - Travel Medicine

D056824 - Upper Extremity Deep Vein Thrombosis

D007103 - Immobilization

D054556 - Venous Thromboembolism

D000925 - Anticoagulants

D011315 - Preventive Medicine

D057236 - Travel Medicine

D056824 - Upper Extremity Deep Vein Thrombosis

D007103 - Immobilization

Keywords
Antithrombotic Agents, Venous Thromboembolism, anticoagulation, antiplatelet agents, cancer, deep venous thrombosis, immobility, thrombophilia, travel medicine
Target Patient Population
Hospitalized medical patients, outpatients with cancer, the chronically immobilized, long-distance travelers, and those with asymptomatic thrombophilia
Inclusion Criteria
Male, Female, Adolescent, Adult, Older Adult
Health Care Settings
Ambulatory, Emergency Care, Hospital, Long Term Care, Outpatient
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Supplemental Methodology Resource
Data Supplement
Number of Source Documents
173
Includes peer/external review process?
Yes
Includes public comment process?
No
Methodologist involvement?
Yes
Patient involvement?
Yes
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
Yes
Grades quality of strength of recommendation?
Yes
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
Includes benefits/harms analysis with recommendations?
Yes
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.